Endometrial cancer is a clinically heterogeneous disease and it is becoming increasingly
clear that this heterogeneity may be a function of the diversity of the underlying molecular …

Endometrial carcinoma (EC) is the fourth most common cancer in women in the developed
world. Classification of ECs by histomorphologic criteria has limited reproducibility and …

Background: Classification of endometrial carcinomas (ECs) by morphologic features is
inconsistent, and yields limited prognostic and predictive information. A new system for …

Objective Categorization and risk stratification of endometrial carcinomas is inadequate;
histomorphologic assessment shows considerable interobserver variability, and risk of …

Endometrial carcinoma (EC) can be divided into 4 prognostic molecular subtypes, and no
specific molecular profile (NSMP) type is the most commonly occurring type (∼ 50%) …

OBJECTIVE: To assess the agreement between preoperative endometrial sampling and
final diagnosis for tumor grade and subtype in patients with endometrial carcinoma. DATA …

Background The role of lymph node assessment/dissection (LND) in endometrial cancer
(EC) has been debated for decades, with significant practice variation between centers …

Objective Molecular alterations in endometrial cancer have been shown to be prognostically
significant but have not yet been implemented in the current clinical risk assessment. Few …

Objective While the accuracy of the Sentinel Lymph Node (SLN) procedure has been
validated in patients with early-stage endometrial cancer (EC) at low and intermediate risk of …

Endometrial cancer is the most common cancer of the female genital tract in developed
countries. Although the majority of endometrial cancers are diagnosed at early stages and …